MedPath

Early Detection and Treatment of Respiratory Sleep Disorders in Children With Down Syndrome

Not Applicable
Active, not recruiting
Conditions
Obstructive Sleep Apnea of Newborn
Down Syndrome
Registration Number
NCT03210675
Lead Sponsor
Institut Jerome Lejeune
Brief Summary

Interventional, comparative, open label, single-center study to demonstrate that an early (from 6 months of age) and systematic (every 6 months) screening of Obstructive Sleep Apnea (OSA) by polysomnography (PSG) in children with Down Syndrome during the first 3 years of life is associated with an improved neurocognitive development at the age of 3 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean Griffith Mental Development Scale (GMDS) scoresAt the age of 3 years

Mean Griffith Mental Development Scale (GMDS) scores at the age of 3 years will be compared between the 2 groups

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Jérome Lejeune

🇫🇷

Paris, France

Institut Jérome Lejeune
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.